DEFENDER Trial: Dapagliflozin for Critically Ill Patients with Acute Organ Dysfunction -Implications for clinicians

Affiliations

• ¹ Department of Nephrology, Dialysis and Internal Medicine, Warsaw Medical University, Warsaw, Poland.
• ² Service of Nephrology and Hypertension, University Hospital of Geneva, Geneva, Switzerland.
• ³ Nephrology and Kidney Transplantation Unit, Department of Translational Medicine (DIMET), University of Piemonte Orientale (UPO), "Maggiore della Carità" University Hospital, Novara, Italy.
• ⁴ Department of Nephrology and Organ Transplantation, Intensive Care Unit, University Hospital of Toulouse, INSERM U1297 (Institute of Metabolic and Cardiovascular Diseases), French Intensive Care Renal Network, Toulouse, France.
• ⁵ Nephrology and Renal Transplantation Department, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.
• ⁶ Laboratory of Experimental Nephrology, Instituto de Investigación Sanitaria Fundacion Jimenez Diaz (IIS-FJD), Universidad Autonoma de Madrid, RICORS2040, Madrid, Spain.
• ⁷ Centre for Kidney Research and Innovation, Academic Unit for Translational Medical Sciences, University of Nottingham, Royal Derby Hospital Campus, Derby, UK.
• ⁸ Division of Nephrology and Clinical Immunology, University Hospital RWTH Aachen, Aachen, Germany.
• ⁹ Guy's & St Thomas' Hospital, Department of Critical Care & Nephrology, London, UK.